Table 1 Correlation between RBP7 expression and clinicopathological features in HR + BC patients
Title | Group | RBP7 expression(%) | Total | χ2 | P | |
|---|---|---|---|---|---|---|
high | low | |||||
Stage | I | 1(2.63) | 0(0.00) | 1(1.45) | 1.981 | 0.852 |
IIA | 9(23.68) | 5(16.13) | 14(20.29) | |||
IIB | 7(18.42) | 6(19.35) | 13(18.84) | |||
IIIA | 18(47.37) | 16(51.61) | 34(49.28) | |||
IIIB | 1(2.63) | 2(6.45) | 3(4.35) | |||
IIIC | 2(5.26) | 2(6.45) | 4(5.80) | |||
Ki-67 | low | 20(52.63) | 25(80.65) | 45(65.22) | 5.906 | 0.015* |
high | 18(47.37) | 6(19.35) | 24(34.78) | |||
T | I-II | 35(92.11) | 23(74.19) | 58(84.06) | 4.087 | 0.043* |
III-IV | 3(7.89) | 8(25.81) | 11(15.94) | |||
N | 0 | 11(28.95) | 5(16.13) | 16(23.19) | 1.575 | 0.209 |
I-III | 27(71.05) | 26(83.87) | 53(76.81) | |||
Age | ≥ 60 | 7(18.42) | 5(16.13) | 12(17.39) | 0.062 | 0.803 |
<60 | 31(81.58) | 26(83.87) | 57(82.61) | |||
Total | 38 | 31 | 69 | |||